Cleveland Clinic posted an operating income of $206.2 million (4.5% margin) in the third quarter, a notable improvement from the $43.4 million operating gain (1.1% margin) reported in the same quarter last year, according to financial documents published Nov. 14.
Five things to know:
1. Year-to-date operating income stands at $514.4 million (3.7% margin), up from $138.9 million (1.2% margin) during the same nine-month period in 2024.
2. Third-quarter revenue totaled $4.5 billion, up from $4 billion in the same period in 2024. Net patient service revenue was $3.7 billion, up from $3.4 billion.
3. Operating expenses rose to $4.1 billion in the third quarter of 2025, up from $3.7 billion in the third quarter of 2024. The largest contributors were salaries and wages ($2.3 billion), pharmaceutical supplies ($701 million), and medical supplies ($427 million).
4. After accounting for nonoperating items, such as investment returns, Cleveland Clinic reported a third-quarter net income of $706 million (15.5% margin), up from a $375 million net gain (9.4% margin) in the prior-year period. .
5. As of Sept 30, 2025, Cleveland Clinic had $5.1 billion in long-term debt, $18.5 billion in total assets and $1.1 billion in cash and cash equivalents.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
